| Year |
Citation |
Score |
| 2024 |
Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, ... ... Monto AS, et al. Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years. Jama. 331: 408-416. PMID 38319331 DOI: 10.1001/jama.2023.27022 |
0.334 |
|
| 2023 |
Ahmed F, Nowalk MP, Zimmerman RK, Bear T, Grijalva CG, Talbot HK, Florea A, Tartof SY, Gaglani M, Smith M, McLean HQ, King JP, Martin ET, Monto AS, Phillips CH, et al. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. Emerging Infectious Diseases. 29. PMID 37917142 DOI: 10.3201/eid2912.231070 |
0.332 |
|
| 2023 |
Rumfelt KE, Fitzsimmons WJ, Truscon R, Monto AS, Martin ET, Lauring AS. A rapid and flexible microneutralization assay for serological assessment of influenza viruses. Influenza and Other Respiratory Viruses. 17: e13141. PMID 37127782 DOI: 10.1111/irv.13141 |
0.445 |
|
| 2023 |
DeCuir J, Surie D, Zhu Y, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Phan M, ... ... Monto AS, et al. Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. Mmwr. Morbidity and Mortality Weekly Report. 72: 463-468. PMID 37104244 DOI: 10.15585/mmwr.mm7217a3 |
0.341 |
|
| 2023 |
Hood N, Flannery B, Gaglani M, Beeram M, Wernli K, Jackson ML, Martin ET, Monto AS, Zimmerman R, Raviotta J, Belongia EA, McLean HQ, Kim S, Patel MM, Chung JR. Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. PMID 36960655 DOI: 10.1542/peds.2022-059922 |
0.558 |
|
| 2023 |
Fine SR, Bazzi LA, Callear AP, Petrie JG, Malosh RE, Foster-Tucker JE, Smith M, Ibiebele J, McDermott A, Rolfes MA, Monto AS, Martin ET. Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort. Influenza and Other Respiratory Viruses. 17: e13106. PMID 36875204 DOI: 10.1111/irv.13106 |
0.489 |
|
| 2023 |
Begley KM, Monto AS, Lamerato LE, Malani AN, Lauring AS, Talbot HK, Gaglani M, McNeal T, Silveira FP, Zimmerman RK, Middleton DB, Ghamande S, Murthy K, Kim L, Ferdinands JM, et al. Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults Hospitalized with Acute Respiratory Illness from a Prospective Multicenter Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36694363 DOI: 10.1093/cid/ciad031 |
0.31 |
|
| 2022 |
Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, et al. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and Other Respiratory Viruses. 16: 975-985. PMID 36825251 DOI: 10.1111/irv.13029 |
0.321 |
|
| 2022 |
Lewis NM, Murray N, Adams K, Surie D, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, ... ... Monto AS, et al. Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. Open Forum Infectious Diseases. 10: ofac698. PMID 36695662 DOI: 10.1093/ofid/ofac698 |
0.399 |
|
| 2022 |
Fine SR, Bazzi LA, Callear AP, Petrie JG, Malosh RE, Tucker JE, Smith M, Ibiebele J, McDermott A, Rolfes MA, Monto AS, Martin ET. Respiratory Virus Circulation during the First Year of the COVID-19 Pandemic in the Household Influenza Vaccine Evaluation (HIVE) Cohort. Medrxiv : the Preprint Server For Health Sciences. PMID 36523413 DOI: 10.1101/2022.12.08.22283268 |
0.475 |
|
| 2022 |
Price AM, Flannery B, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Mutnal M, Geffel KM, Nowalk MP, Tartof SY, et al. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36504336 DOI: 10.1093/cid/ciac941 |
0.538 |
|
| 2022 |
Monto AS, Lauring AS, Martin ET. SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza. The Journal of Infectious Diseases. PMID 36424890 DOI: 10.1093/infdis/jiac454 |
0.461 |
|
| 2022 |
Jackson ML, Phillips CH, Wellwood S, Kiniry E, Jackson LA, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Dunnigan K, Raiyani C, Murthy K, Flannery B, Chung JR. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. Vaccine. PMID 36379754 DOI: 10.1016/j.vaccine.2022.11.011 |
0.543 |
|
| 2022 |
Malosh RE, McGovern I, Monto AS. Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36219562 DOI: 10.1093/cid/ciac653 |
0.521 |
|
| 2022 |
Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet (London, England). 400: 693-706. PMID 36030813 DOI: 10.1016/S0140-6736(22)00982-5 |
0.552 |
|
| 2022 |
Adams K, Rhoads JP, Surie D, Gaglani M, Ginde AA, McNeal T, Ghamande S, Huynh D, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, ... ... Monto AS, et al. Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States. Medrxiv : the Preprint Server For Health Sciences. PMID 35734090 DOI: 10.1101/2022.06.09.22276228 |
0.386 |
|
| 2022 |
Lewis NM, Self WH, Gaglani M, Ginde AA, Douin DJ, Keipp Talbot H, Casey JD, Mohr NM, Zepeski A, Ghamande SA, McNeal TA, Shapiro NI, Gibbs KW, Files DC, Hager DN, ... ... Monto AS, et al. Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35675695 DOI: 10.1093/cid/ciac439 |
0.326 |
|
| 2022 |
Christensen SR, Martin ET, Petrie JG, Monto AS, Hensley SE. The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade. Journal of Virology. e0220021. PMID 35588275 DOI: 10.1128/jvi.02200-21 |
0.339 |
|
| 2022 |
Tenforde MW, Self WH, Zhu Y, Naioti EA, Gaglani M, Ginde AA, Jensen K, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, ... ... Monto AS, et al. Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35580849 DOI: 10.1093/cid/ciac381 |
0.369 |
|
| 2022 |
Tenforde MW, Self WH, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, ... ... Monto AS, et al. Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 459-465. PMID 35324878 DOI: 10.15585/mmwr.mm7112e1 |
0.399 |
|
| 2022 |
Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, et al. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 365-370. PMID 35271561 DOI: 10.15585/mmwr.mm7110a1 |
0.572 |
|
| 2022 |
Monto AS. The Future of SARS-CoV-2 Vaccination. Reply. The New England Journal of Medicine. 386: 899-900. PMID 35235738 DOI: 10.1056/NEJMc2119437 |
0.409 |
|
| 2022 |
Chung JR, Kim SS, Belongia EA, McLean HQ, King JP, Nowalk MP, Zimmerman RK, Moehling Geffel K, Martin ET, Monto AS, Lamerato LE, Gaglani M, Hoffman E, Volz M, Jackson ML, et al. Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021. Influenza and Other Respiratory Viruses. PMID 35170231 DOI: 10.1111/irv.12973 |
0.357 |
|
| 2021 |
Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet. Microbe. 2: e715-e725. PMID 35544110 DOI: 10.1016/S2666-5247(21)00180-4 |
0.505 |
|
| 2021 |
DeJonge PM, Monto AS, Malosh RE, Petrie JG, Segaloff HE, McSpadden E, Cheng C, Bazzi L, Callear A, Johnson E, Truscon R, Martin ET. Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan. Influenza and Other Respiratory Viruses. PMID 34821476 DOI: 10.1111/irv.12944 |
0.394 |
|
| 2021 |
Monto AS. The Future of SARS-CoV-2 Vaccination - Lessons from Influenza. The New England Journal of Medicine. 385: 1825-1827. PMID 34739199 DOI: 10.1056/NEJMp2113403 |
0.524 |
|
| 2021 |
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, ... ... Monto AS, et al. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. Jama. PMID 34734975 DOI: 10.1001/jama.2021.19499 |
0.371 |
|
| 2021 |
Self WH, Tenforde MW, Rhoads JP, Gaglani M, Ginde AA, Douin DJ, Olson SM, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, ... ... Monto AS, et al. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1337-1343. PMID 34555004 DOI: 10.15585/mmwr.mm7038e1 |
0.427 |
|
| 2021 |
Thompson MG, Soto G, Perez A, Newes-Adeyim G, Yoo YM, Hirsch A, Katz M, Tinoco Y, Shemer Avni Y, Ticona E, Malosh R, Martin E, Matos E, Reynolds S, Wesley M, ... ... Monto A, et al. Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019. Vaccine. PMID 34509322 DOI: 10.1016/j.vaccine.2021.07.077 |
0.54 |
|
| 2021 |
Kim SS, Chung JR, Belongia EA, McLean HQ, King JP, Nowalk MP, Zimmerman RK, Balasubramani GK, Martin ET, Monto AS, Lamerato LE, Gaglani M, Smith ME, Dunnigan KM, Jackson ML, et al. mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021. The Journal of Infectious Diseases. PMID 34498052 DOI: 10.1093/infdis/jiab451 |
0.398 |
|
| 2021 |
Tenforde MW, Self WH, Naioti EA, Ginde AA, Douin DJ, Olson SM, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, ... ... Monto AS, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1156-1162. PMID 34437524 DOI: 10.15585/mmwr.mm7034e2 |
0.364 |
|
| 2021 |
Petrie JG, Fligiel H, Lamerato L, Martin ET, Monto AS. Agreement between state registry, health record, and self-report of influenza vaccination. Vaccine. PMID 34384635 DOI: 10.1016/j.vaccine.2021.07.090 |
0.476 |
|
| 2021 |
Tenforde MW, Patel MM, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, ... ... Monto AS, et al. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34358310 DOI: 10.1093/cid/ciab687 |
0.34 |
|
| 2021 |
Ghamande S, Shaver C, Murthy K, Raiyani C, White HD, Lat T, Arroliga AC, Wyatt D, Talbot HK, Martin ET, Monto AS, Zimmerman RK, Middleton DB, Silveira FP, Ferdinands JM, et al. Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34320171 DOI: 10.1093/cid/ciab654 |
0.491 |
|
| 2021 |
Griggs EP, Flannery B, Foppa IM, Gaglani M, Murthy K, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Martin ET, Monto AS, Zimmerman RK, Balasubramani GK, Chung JR, Patel M, et al. Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network. American Journal of Epidemiology. PMID 34274963 DOI: 10.1093/aje/kwab205 |
0.516 |
|
| 2021 |
Tenforde MW, Patel MM, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, ... ... Monto AS, et al. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. Medrxiv : the Preprint Server For Health Sciences. PMID 34268515 DOI: 10.1101/2021.07.08.21259776 |
0.34 |
|
| 2021 |
Hayden FG, Asher J, Cowling BJ, Hurt AC, Ikematsu H, Kuhlbusch K, Lemenuel-Diot A, Du Z, Meyers LA, Piedra PA, Takazono T, Yen HL, Monto AS. Reducing influenza virus transmission: the value of antiviral treatment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34245250 DOI: 10.1093/cid/ciab625 |
0.607 |
|
| 2021 |
Talbot HK, Martin ET, Gaglani M, Middleton DB, Ghamande S, Silveira FP, Murthy K, Zimmerman RK, Trabue CH, Olson SM, Petrie JG, Ferdinands JM, Patel MM, Monto AS. Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34050659 DOI: 10.1093/cid/ciab123 |
0.397 |
|
| 2021 |
Chung JR, Flannery B, Kim SS, Gaglani M, Raiyani C, Belongia EA, McLean HQ, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Martin ET, Monto AS, Patel M. Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. Vaccine. PMID 33994240 DOI: 10.1016/j.vaccine.2021.05.004 |
0.489 |
|
| 2021 |
Tenforde MW, Olson SM, Self WH, Talbot HK, Lindsell CJ, Steingrub JS, Shapiro NI, Ginde AA, Douin DJ, Prekker ME, Brown SM, Peltan ID, Gong MN, Mohamed A, Khan A, ... ... Monto AS, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 674-679. PMID 33956782 DOI: 10.15585/mmwr.mm7018e1 |
0.366 |
|
| 2021 |
Malosh RE, Petrie JG, Callear A, Truscon R, Johnson E, Evans R, Bazzi L, Cheng C, Thompson MS, Martin ET, Monto AS. Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33949666 DOI: 10.1093/cid/ciab395 |
0.519 |
|
| 2021 |
Petrie JG, Bazzi LA, McDermott AB, Follmann D, Esposito D, Hatcher C, Mateja A, Narpala SR, O'Connell SE, Martin ET, Monto AS. Coronavirus Occurrence in the HIVE Cohort of Michigan Households: Reinfection frequency and serologic responses to seasonal and SARS coronaviruses. The Journal of Infectious Diseases. PMID 33755731 DOI: 10.1093/infdis/jiab161 |
0.396 |
|
| 2021 |
Wu MJ, Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Gaglani M, Reis M, Beeram M, Martin ET, Monto AS, Nowalk MP, Zimmerman R, Santibanez TA, et al. Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. Vaccine. PMID 33597114 DOI: 10.1016/j.vaccine.2021.01.065 |
0.483 |
|
| 2021 |
Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, King JP, Zimmerman RK, Nowalk MP, Martin ET, Monto AS, Gaglani M, Smith ME, Patel M, Flannery B. Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infectious Diseases. 8: ofaa576. PMID 33537361 DOI: 10.1093/ofid/ofaa576 |
0.31 |
|
| 2021 |
Ferdinands JM, Gaglani M, Martin ET, Monto AS, Middleton D, Silveira F, Talbot HK, Zimmerman R, Patel M. Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33462610 DOI: 10.1093/cid/ciab045 |
0.523 |
|
| 2020 |
Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TM, Monto AS, Martin ET, Zimmerman RK, Silveira F, Middleton DB, Olson SM, Garten Kondor RJ, Barnes JR, Ferdinands JM, Patel MM, et al. Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020. The Journal of Infectious Diseases. PMID 33378531 DOI: 10.1093/infdis/jiaa800 |
0.454 |
|
| 2020 |
Tenforde MW, Kondor RJG, Chung JR, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Rao A, Kim SS, Stark TJ, et al. Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33367650 DOI: 10.1093/cid/ciaa1884 |
0.502 |
|
| 2020 |
Ferdinands JM, Gaglani M, Ghamande S, Martin ET, Middleton D, Monto AS, Silveira F, Talbot HK, Zimmerman R, Smith ER, Patel M. Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network. The Journal of Infectious Diseases. PMID 33336702 DOI: 10.1093/infdis/jiaa772 |
0.486 |
|
| 2020 |
Martin ET, Cheng C, Petrie JG, Alyanak E, Gaglani M, Middleton DB, Ghamande S, Silveira FP, Murthy K, Zimmerman RK, Monto AS, Trabue C, Talbot HK, Ferdinands JM. Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). The Journal of Infectious Diseases. PMID 33140094 DOI: 10.1093/infdis/jiaa685 |
0.513 |
|
| 2020 |
Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, Shu Y, Tam JS. Influenza and COVID-19: What does co-existence mean? Influenza and Other Respiratory Viruses. PMID 33128444 DOI: 10.1111/irv.12824 |
0.418 |
|
| 2020 |
Malosh RE, Petrie JG, Callear AP, Monto AS, Martin ET. Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study. Influenza and Other Respiratory Viruses. PMID 33107200 DOI: 10.1111/irv.12822 |
0.464 |
|
| 2020 |
Gouma S, Kim K, Weirick ME, Gumina ME, Branche A, Topham DJ, Martin ET, Monto AS, Cobey S, Hensley SE. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nature Communications. 11: 4566. PMID 32917903 DOI: 10.1038/S41467-020-18465-X |
0.512 |
|
| 2020 |
Balasubramani GK, Choi WS, Nowalk MP, Zimmerman RK, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Jackson ML, Jackson LA, Chung JR, Spencer S, Fry AM, et al. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. Vaccine. PMID 32800465 DOI: 10.1016/J.Vaccine.2020.08.011 |
0.559 |
|
| 2020 |
Kim SS, Flannery B, Foppa IM, Chung JR, Nowalk MP, Zimmerman RK, Gaglani M, Monto AS, Martin ET, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Patel M. Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32505128 DOI: 10.1093/Cid/Ciaa706 |
0.498 |
|
| 2020 |
Perera RA, Mok CK, Tsang OT, Lv H, Ko RL, Wu NC, Yuan M, Leung WS, Chan JM, Chik TS, Choi CY, Leung K, Chan KH, Chan KC, Li KC, ... ... Monto AS, et al. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 25. PMID 32347204 DOI: 10.2807/1560-7917.Es.2020.25.16.2000421 |
0.334 |
|
| 2020 |
Smith ER, Fry AM, Hicks LA, Fleming-Dutra KE, Flannery B, Ferdinands J, Rolfes MA, Martin ET, Monto AS, Zimmerman RK, Nowalk MP, Jackson ML, McLean HQ, Olson SC, Gaglani M, et al. Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32322875 DOI: 10.1093/Cid/Ciaa464 |
0.51 |
|
| 2020 |
Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR, Martin ET, Monto AS, Jackson ML, Gaglani MJ, Flannery B, Chung JR, Zimmerman RK. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Influenza and Other Respiratory Viruses. PMID 32298048 DOI: 10.1111/Irv.12741 |
0.593 |
|
| 2020 |
Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, et al. Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32270198 DOI: 10.1093/Cid/Ciaa407 |
0.546 |
|
| 2020 |
Monto AS, DeJonge P, Callear AP, Bazzi LA, Capriola S, Malosh RE, Martin ET, Petrie JG. Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. The Journal of Infectious Diseases. PMID 32246136 DOI: 10.1093/Infdis/Jiaa161 |
0.541 |
|
| 2020 |
Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, et al. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. Mmwr. Morbidity and Mortality Weekly Report. 69: 177-182. PMID 32078591 DOI: 10.15585/Mmwr.Mm6907A1 |
0.633 |
|
| 2020 |
Doyle JD, Beacham L, Martin ET, Talbot HK, Monto A, Gaglani M, Middleton DB, Silveira FP, Zimmerman RK, Alyanak E, Smith ER, Flannery BL, Rolfes M, Ferdinands JM. Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32067049 DOI: 10.1093/Cid/Ciaa160 |
0.566 |
|
| 2020 |
Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, et al. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32006430 DOI: 10.1093/Cid/Ciaa102 |
0.567 |
|
| 2019 |
Valesano AL, Fitzsimmons WJ, McCrone JT, Petrie JG, Monto AS, Martin ET, Lauring AS. Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts. Journal of Virology. PMID 31801858 DOI: 10.1128/Jvi.01710-19 |
0.548 |
|
| 2019 |
Segaloff HE, Cheng B, Miller AV, Petrie JG, Malosh RE, Cheng C, Lauring AS, Lamerato L, Ferdinands JM, Monto AS, Martin ET. Influenza Vaccine Effectiveness in the Inpatient Setting; Evaluation of Potential Bias in the Test Negative Design by use of Alternate Control Groups. American Journal of Epidemiology. PMID 31673696 DOI: 10.1093/Aje/Kwz248 |
0.596 |
|
| 2019 |
Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season. The Journal of Infectious Diseases. PMID 31665373 DOI: 10.1093/Infdis/Jiz543 |
0.605 |
|
| 2019 |
Roosenhoff R, Reed V, Kenwright A, Schutten M, Boucher CA, Monto A, Clinch B, Kumar D, Whitley R, Nguyen-Van-Tam JS, Osterhaus ADME, Fouchier RAM, Fraaij PLA. Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31560055 DOI: 10.1093/Cid/Ciz939 |
0.505 |
|
| 2019 |
Whitley RJ, Monto AS. Resistance of Influenza Virus to Antiviral Medications. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31538179 DOI: 10.1093/Cid/Ciz911 |
0.455 |
|
| 2019 |
Monto AS, Fukuda K. Lessons from Influenza Pandemics of the last 100 Years. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31420670 DOI: 10.1093/Cid/Ciz803 |
0.566 |
|
| 2019 |
Monto AS. Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31408517 DOI: 10.1093/Cid/Ciz722 |
0.558 |
|
| 2019 |
Gilbert PB, Fong Y, Juraska M, Carpp LN, Monto AS, Martin ET, Petrie JG. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy. Bmc Infectious Diseases. 19: 453. PMID 31117986 DOI: 10.1186/S12879-019-4049-5 |
0.596 |
|
| 2019 |
Petrie JG, Martin ET, Zhu Y, Wyatt DG, Kaniclides A, Ferdinands JM, Monto AS, Trabue C, Talbot HK. Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness. Vaccine. PMID 31113675 DOI: 10.1016/J.Vaccine.2019.05.051 |
0.559 |
|
| 2019 |
Monto AS, Petrie JG. Improving influenza vaccine effectiveness: ways to begin solving the problem. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31102404 DOI: 10.1093/Cid/Ciz416 |
0.528 |
|
| 2019 |
Malosh RE, Noppert GA, Zelner J, Martin ET, Monto AS. Social patterning of acute respiratory illnesses in the Household Influenza Vaccine Evaluation (HIVE) Study 2014-2015. Epidemiology and Infection. 147: e185. PMID 31063118 DOI: 10.1017/S0950268819000748 |
0.41 |
|
| 2019 |
Monto AS, Malosh RE, Evans R, Lauring AS, Gordon A, Thompson MG, Fry AM, Flannery B, Ohmit SE, Petrie JG, Martin ET. Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study. International Journal of Epidemiology. PMID 31038700 DOI: 10.1093/Ije/Dyz086 |
0.562 |
|
| 2019 |
Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Foust A, Sessions W, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. Mmwr. Morbidity and Mortality Weekly Report. 68: 135-139. PMID 30763298 DOI: 10.15585/Mmwr.Mm6806A2 |
0.636 |
|
| 2019 |
Segaloff HE, Leventer-Roberts M, Riesel D, Malosh RE, Feldman BS, Shemer-Avni Y, Key C, Monto AS, Martin ET, Katz MA. Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30753347 DOI: 10.1093/Cid/Ciz125 |
0.594 |
|
| 2019 |
Petrie JG, Martin ET, Truscon R, Johnson E, Cheng CK, McSpadden EJ, Malosh RE, Lauring AS, Lamerato LE, Eichelberger MC, Ferdinands JM, Monto AS. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population. Vaccine. PMID 30738647 DOI: 10.1016/J.Vaccine.2019.01.055 |
0.608 |
|
| 2019 |
Zelner J, Petrie JG, Trangucci R, Martin ET, Monto AS. Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning. The Journal of Infectious Diseases. PMID 30722022 DOI: 10.1093/Infdis/Jiz055 |
0.583 |
|
| 2019 |
Levine MZ, Martin ET, Petrie JG, Lauring AS, Holiday C, Jefferson S, Fitzsimmons WJ, Johnson E, Ferdinands JM, Monto AS. Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season. The Journal of Infectious Diseases. PMID 30721982 DOI: 10.1093/Infdis/Jiz049 |
0.61 |
|
| 2019 |
Eichelberger MC, Monto AS. Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection. The Journal of Infectious Diseases. PMID 30715357 DOI: 10.1093/Infdis/Jiz017 |
0.56 |
|
| 2019 |
Rolfes MA, Flannery B, Chung J, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman R, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, et al. Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30715278 DOI: 10.1093/Cid/Ciz075 |
0.619 |
|
| 2019 |
Christensen SR, Toulmin SA, Griesman T, Lamerato LE, Petrie JG, Martin ET, Monto AS, Hensley SE. Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans. Journal of Virology. PMID 30700610 DOI: 10.1128/Jvi.02134-18 |
0.532 |
|
| 2019 |
Kim SS, Foppa I, Chung JR, Belongia E, McLean H, Monto A, Petrie, JG, Zimmerman R, Nowalk MP, Gaglani M, Murthy K, Jackson ML, Flannery B, Patel M. 2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018 Open Forum Infectious Diseases. 6: S973-S973. DOI: 10.1093/Ofid/Ofz360.2437 |
0.568 |
|
| 2019 |
Ladva CN, Belongia E, Monto A, Martin ET, Gaglani M, Reis M, Jackson ML, Jackson L, Zimmerman R, Nowalk MP, McLean H, Patel M, Fry AM, Flannery B. 2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018 Open Forum Infectious Diseases. 6: S962-S962. DOI: 10.1093/Ofid/Ofz360.2412 |
0.588 |
|
| 2019 |
DeJonge P, Malosh R, Truscon R, Johnson E, Foote S, Cheng B, Tiseo KE, Getz AS, Segaloff H, Monto A, Martin ET. 1642. Comparing Viral Respiratory Infections Between Children Who Do and Do Not Attend Child Care Open Forum Infectious Diseases. 6: S599-S599. DOI: 10.1093/Ofid/Ofz360.1506 |
0.357 |
|
| 2019 |
Chung JR, Flannery B, Gaglani M, Reis E, Hickey R, McLean H, Jackson ML, Belongia E, Smith M, Martin ET, Monto A, Thompson MG, Kim SS, Patel M. 900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018 Open Forum Infectious Diseases. 6: S27-S27. DOI: 10.1093/Ofid/Ofz359.059 |
0.558 |
|
| 2018 |
Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, Silveira FP, Talbot HK, Zimmerman R, Alyanak E, Strickland C, Spencer S, Fry AM. Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). The Journal of Infectious Diseases. PMID 30561689 DOI: 10.1093/Infdis/Jiy723 |
0.557 |
|
| 2018 |
Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine. PMID 30420119 DOI: 10.1016/j.vaccine.2018.10.093 |
0.457 |
|
| 2018 |
Appiah GD, Chung JR, Flannery B, Havers F, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM. Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16. Influenza and Other Respiratory Viruses. PMID 30408341 DOI: 10.1111/Irv.12616 |
0.521 |
|
| 2018 |
Hirsch A, Katz MA, Laufer Peretz A, Greenberg D, Wendlandt R, Shemer Avni Y, Newes-Adeyi G, Gofer I, Leventer-Roberts M, Davidovitch N, Rosenthal A, Gur-Arie R, Hertz T, Glatman-Freedman A, Monto AS, et al. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. Bmc Infectious Diseases. 18: 550. PMID 30400834 DOI: 10.1186/S12879-018-3444-7 |
0.637 |
|
| 2018 |
Havers FP, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, Fry AM, Flannery B. Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30371753 DOI: 10.1093/Cid/Ciy780 |
0.585 |
|
| 2018 |
Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM, et al. Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30204854 DOI: 10.1093/Cid/Ciy775 |
0.624 |
|
| 2018 |
Davis AKF, McCormick K, Gumina ME, Petrie JG, Martin ET, Xue KS, Bloom JD, Monto AS, Bushman FD, Hensley SE. Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations . Journal of Virology. PMID 30045982 DOI: 10.1128/Jvi.00859-18 |
0.447 |
|
| 2018 |
Segaloff HE, Petrie JG, Malosh RE, Cheng CK, McSpadden EJ, Ferdinands JM, Lamerato L, Lauring AS, Monto AS, Martin ET. Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016. Epidemiology and Infection. 1-9. PMID 29880077 DOI: 10.1017/S0950268818001486 |
0.477 |
|
| 2018 |
Garretson TA, Petrie JG, Martin ET, Monto AS, Hensley SE. Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain. Vaccine. PMID 29861178 DOI: 10.1016/J.Vaccine.2018.05.086 |
0.538 |
|
| 2018 |
McCrone JT, Woods RJ, Martin ET, Malosh RE, Monto AS, Lauring AS. Stochastic processes constrain the within and between host evolution of influenza virus. Elife. 7. PMID 29683424 DOI: 10.7554/Elife.35962 |
0.464 |
|
| 2018 |
Krammer F, Fouchier RAM, Eichelberger MC, Webby RJ, Shaw-Saliba K, Wan H, Wilson PC, Compans RW, Skountzou I, Monto AS. NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? Mbio. 9. PMID 29615508 DOI: 10.1128/Mbio.02332-17 |
0.595 |
|
| 2018 |
Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 18: 1020-1025. PMID 29603606 DOI: 10.1111/ajt.14730 |
0.452 |
|
| 2018 |
Monto AS. Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control. Influenza and Other Respiratory Viruses. 12: 10-12. PMID 29460424 DOI: 10.1111/Irv.12511 |
0.513 |
|
| 2018 |
Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, et al. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. Mmwr. Morbidity and Mortality Weekly Report. 67: 180-185. PMID 29447141 DOI: 10.1111/Ajt.14730 |
0.639 |
|
| 2018 |
Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine. PMID 29402578 DOI: 10.1016/j.vaccine.2018.01.045 |
0.378 |
|
| 2018 |
Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, et al. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. The Journal of Infectious Diseases. PMID 29361005 DOI: 10.1093/Infdis/Jix634 |
0.619 |
|
| 2018 |
McCrone JT, Woods RJ, Martin ET, Malosh RE, Monto AS, Lauring AS. Author response: Stochastic processes constrain the within and between host evolution of influenza virus Elife. DOI: 10.7554/Elife.35962.036 |
0.453 |
|
| 2018 |
Malosh RE, Evans R, Martin ET, Petrie JG, Monto AS. 997. Protection of Unvaccinated Individuals by Influenza Vaccine Coverage of Household Contacts Open Forum Infectious Diseases. 5: S296-S297. DOI: 10.1093/Ofid/Ofy210.834 |
0.59 |
|
| 2018 |
Alyanak E, Gaglani M, Martin ET, Monto AS, Middleton D, Silveira FP, Zimmerman R, Talbot HK, Ferdinands JM. 995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016 Open Forum Infectious Diseases. 5: S296-S296. DOI: 10.1093/Ofid/Ofy210.832 |
0.555 |
|
| 2018 |
Flannery BL, Chung J, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia E, McLean H, Zimmerman RK, Nowalk MP, Gaglani M, Griffin MR, Talbot HK, Treanor JJ, Spencer S, et al. 988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018 Open Forum Infectious Diseases. 5: S292-S292. DOI: 10.1093/Ofid/Ofy210.825 |
0.585 |
|
| 2017 |
Lina B, Boucher C, Osterhaus A, Monto AS, Schutten M, Whitley RJ, Nguyen-Van-Tam JS. Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (IRIS). Influenza and Other Respiratory Viruses. PMID 29265727 DOI: 10.1111/Irv.12534 |
0.458 |
|
| 2017 |
Ainslie KEC, Haber MJ, Malosh RE, Petrie JG, Monto AS. Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community. Statistics in Medicine. PMID 29193179 DOI: 10.1002/Sim.7558 |
0.594 |
|
| 2017 |
Malosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS. Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29186364 DOI: 10.1093/Cid/Cix1040 |
0.318 |
|
| 2017 |
Malosh RE, Martin ET, Ortiz JR, Monto AS. The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review. Vaccine. PMID 29157959 DOI: 10.1016/J.Vaccine.2017.11.018 |
0.544 |
|
| 2017 |
Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson M, Monto AS, Martin ET, Belongia EA, McLean H, Fry AM, Havers F. Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29069334 DOI: 10.1093/Cid/Cix922 |
0.495 |
|
| 2017 |
Petrie JG, Malosh RE, Cheng CK, Ohmit SE, Martin ET, Johnson E, Truscon R, Eichelberger MC, Gubareva LV, Fry AM, Monto AS. The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020179 DOI: 10.1093/Cid/Cix608 |
0.623 |
|
| 2017 |
Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS. Respiratory syncytial virus hospitalization in middle-aged and older adults. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 96: 37-43. PMID 28942341 DOI: 10.1016/J.Jcv.2017.09.001 |
0.362 |
|
| 2017 |
Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. The New England Journal of Medicine. 377: 534-543. PMID 28792867 DOI: 10.1056/NEJMoa1700153 |
0.54 |
|
| 2017 |
Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM. Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S. The Journal of Infectious Diseases. PMID 28633308 DOI: 10.1093/Infdis/Jix286 |
0.544 |
|
| 2017 |
Petrie JG, Eisenberg MC, Ng S, Malosh RE, Han Lee K, Ohmit SE, Monto AS. Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort. American Journal of Epidemiology. PMID 28605429 DOI: 10.1093/Aje/Kwx217 |
0.491 |
|
| 2017 |
Petrie JG, Monto AS. Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. The Journal of Infectious Diseases. 215: 841-843. PMID 28453852 DOI: 10.1093/Infdis/Jix056 |
0.56 |
|
| 2017 |
Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. The Journal of Infectious Diseases. PMID 28398521 DOI: 10.1093/Infdis/Jix173 |
0.611 |
|
| 2017 |
Fell DB, Bhutta ZA, Hutcheon JA, Karron RA, Knight M, Kramer MS, Monto AS, Swamy GK, Ortiz JR, Savitz DA. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015. Vaccine. PMID 28343772 DOI: 10.1016/J.Vaccine.2017.03.056 |
0.554 |
|
| 2017 |
Monto AS. Moving Toward Improved Influenza Vaccines. The Journal of Infectious Diseases. PMID 28329073 DOI: 10.1093/Infdis/Jiw644 |
0.588 |
|
| 2017 |
Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, et al. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. Mmwr. Morbidity and Mortality Weekly Report. 66: 167-171. PMID 28207689 DOI: 10.15585/Mmwr.Mm6606A3 |
0.644 |
|
| 2017 |
Petrie JG, Monto AS. Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. The Journal of Infectious Diseases. PMID 28170047 DOI: 10.1093/infdis/jix056 |
0.475 |
|
| 2017 |
Debbink K, McCrone JT, Petrie JG, Truscon R, Johnson E, Mantlo EK, Monto AS, Lauring AS. Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses. Plos Pathogens. 13: e1006194. PMID 28141862 DOI: 10.1371/Journal.Ppat.1006194 |
0.603 |
|
| 2017 |
E Segaloff H, Petrie JG, Malosh RE, Cheng CK, Ferdinands JM, Lamerato L, Lauring AS, Monto AS, Martin ET. Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons Open Forum Infectious Diseases. 4: S316-S317. DOI: 10.1093/Ofid/Ofx163.740 |
0.573 |
|
| 2017 |
Havers FP, Russell K, Chung J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery BL. Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016 Open Forum Infectious Diseases. 4: S456-S456. DOI: 10.1093/Ofid/Ofx163.1160 |
0.499 |
|
| 2016 |
Petrie JG, Parkhouse K, Ohmit SE, Malosh RE, Monto AS, Hensley SE. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. The Journal of Infectious Diseases. 214: 1947-1951. PMID 27923954 DOI: 10.1093/Infdis/Jiw479 |
0.559 |
|
| 2016 |
Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27702768 DOI: 10.1093/Cid/Ciw635 |
0.612 |
|
| 2016 |
Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR. Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. Bmc Infectious Diseases. 16: 503. PMID 27659721 DOI: 10.1186/S12879-016-1839-X |
0.515 |
|
| 2016 |
Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM, Monto AS. Influenza Vaccine Effectiveness against Antigenically Drifted Influenza Higher than Expected in Hospitalized Adults: 2014-2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27369320 DOI: 10.1093/Cid/Ciw432 |
0.625 |
|
| 2016 |
Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. The Journal of Infectious Diseases. PMID 27190176 DOI: 10.1093/Infdis/Jiw181 |
0.572 |
|
| 2016 |
Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ, Eichelberger MC, Monto AS. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season. The Journal of Infectious Diseases. PMID 27095420 DOI: 10.1093/Infdis/Jiw105 |
0.582 |
|
| 2016 |
Monto AS, Dobson J, Pocock S, Whitley RJ. Oseltamivir for influenza - Authors' reply. Lancet (London, England). 387: 125. PMID 26841996 DOI: 10.1016/S0140-6736(15)01280-5 |
0.425 |
|
| 2016 |
Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, ... Monto AS, et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. The Journal of Infectious Diseases. PMID 26743842 DOI: 10.1093/Infdis/Jiv577 |
0.622 |
|
| 2016 |
Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, et al. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics. PMID 26738884 DOI: 10.1542/Peds.2015-3279 |
0.611 |
|
| 2016 |
Schicker RS, Flannery B, Chung J, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia E, Eng H, Garg S, Fry AM, et al. Influenza Antiviral Use Among High-Risk Outpatients During Four Recent Influenza Seasons—United States, 2011–2015 Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw194.135 |
0.503 |
|
| 2016 |
Lauring AS, McCrone J, Debbink K, Truscon R, Johnson E, Malosh RE, Petrie JG, Ohmit SE, Monto AS. Next-Generation Sequencing of Influenza Viruses in a Household Cohort Accurately Identifies Transmission Pairs and Reveals a Bottleneck Size of Close to One Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw194.121 |
0.447 |
|
| 2016 |
Malosh RE, Cheng CK, Martin ET, Ferdinands JM, Fry AM, Monto AS. Community-Acquired Pneumonia in Adults Hospitalized With Acute Respiratory Illness During the 2014–2015 Influenza Season: Participant Characteristics and Viral Etiologies Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.944 |
0.431 |
|
| 2016 |
Petrie JG, Cheng CK, Malosh RE, Martin ET, Fry AM, Monto AS. No Evidence of Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza A (H3N2) Viruses in a Household Cohort During the 2014–2015 Influenza Season Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.662 |
0.615 |
|
| 2015 |
Petrie JG, Ohmit SE, Martin ET, Malosh RE, Cheng CK, Lauring AS, Lamerato L, Reyes KC, Lipkovich H, Flannery B, Ferdinands JM, Monto AS. Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. Open Forum Infectious Diseases. 2. PMID 27437428 DOI: 10.1093/ofid/ofv130.09 |
0.506 |
|
| 2015 |
Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ, Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belongia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM. Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 months to 8 Years Old during 2011-2012 and 2012-2013: The Importance of Two Priming Doses. The Pediatric Infectious Disease Journal. PMID 26658375 DOI: 10.1097/Inf.0000000000001006 |
0.561 |
|
| 2015 |
Ohmit SE, Petrie JG, Malosh RE, Johnson E, Truscon R, Aaron B, Martens C, Cheng C, Fry AM, Monto AS. Substantial Influenza Vaccine Effectiveness Observed in Households with Children in a Season in which A (pH1N1) Predominated (2013-2014). The Journal of Infectious Diseases. PMID 26597255 DOI: 10.1093/Infdis/Jiv563 |
0.626 |
|
| 2015 |
Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, Gaglani M, Jackson ML, King JP, Nowalk MP, Benoit J, Robertson A, Thaker SN, Monto AS, Ohmit SE. Illness Severity and Work Productivity Loss among Working Adults with Medically-Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26565004 DOI: 10.1093/Cid/Civ952 |
0.561 |
|
| 2015 |
Monto AS, Dobson J, Pocock S, Whitley RJ. Oseltamivir for influenza - Authors' reply. Lancet (London, England). 386: 1135-6. PMID 26461902 DOI: 10.1016/S0140-6736(15)00204-4 |
0.518 |
|
| 2015 |
Zhao X, Fang VJ, Ohmit SE, Monto AS, Cook AR, Cowling BJ. Quantifying protection against influenza virus infection measured by hemagglutination-inhibition assays in vaccine trials. Epidemiology (Cambridge, Mass.). PMID 26427723 DOI: 10.1097/EDE.0000000000000402 |
0.458 |
|
| 2015 |
Jackson ML, Jackson LA, Kieke B, McClure D, Gaglani M, Murthy K, Malosh R, Monto A, Zimmerman RK, Foppa IM, Flannery B, Thompson MG. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. 33: 5181-7. PMID 26271827 DOI: 10.1016/J.Vaccine.2015.07.098 |
0.598 |
|
| 2015 |
van Essen GE, Openshaw P, Myles P, Monto A, van der Vries E. How should influenza be treated? Focus on antivirals. Vaccine. 33: 7033-6. PMID 26256525 DOI: 10.1016/J.Vaccine.2015.07.066 |
0.434 |
|
| 2015 |
Petrie JG, Ohmit SE, Johnson E, Truscon R, Monto AS. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. The Journal of Infectious Diseases. PMID 26014800 DOI: 10.1093/Infdis/Jiv313 |
0.595 |
|
| 2015 |
Davis BM, Markel H, Navarro A, Wells E, Monto AS, Aiello AE. The Effect of Reactive School Closure on Community Influenza-Like Illness Counts in the State of Michigan During the 2009 H1N1 Pandemic. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: e90-7. PMID 25896795 DOI: 10.1093/Cid/Civ182 |
0.47 |
|
| 2015 |
Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. The Journal of Infectious Diseases. PMID 25858957 DOI: 10.1093/Infdis/Jiv195 |
0.581 |
|
| 2015 |
Havers F, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Eng HF, Lamerato L, Campbell AP, et al. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1677-80. PMID 25722198 DOI: 10.1093/Cid/Civ146 |
0.515 |
|
| 2015 |
Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet (London, England). 385: 1729-37. PMID 25640810 DOI: 10.1016/S0140-6736(14)62449-1 |
0.44 |
|
| 2015 |
Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 10-5. PMID 25590680 |
0.572 |
|
| 2015 |
Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. The Journal of Infectious Diseases. 211: 1519-28. PMID 25416812 DOI: 10.1093/Infdis/Jiu650 |
0.571 |
|
| 2015 |
McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto AS, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. The Journal of Infectious Diseases. 211: 1529-40. PMID 25406334 DOI: 10.1093/Infdis/Jiu647 |
0.586 |
|
| 2015 |
Petrie JG, Ohmit SE, Monto A. Waning Influenza Vaccine Efficacy During the 2007–2008 Influenza Season Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1462 |
0.611 |
|
| 2015 |
Zimmerman RK, Flannery B, Fry AM, Thaker S, Clippard J, Jackson M, Belongia E, Mclean H, Gaglani M, Spencer S, Jackson LA, Clipper L, Malosh RE, Monto A, Saul S, et al. Influenza Vaccine Effectiveness in the 2014–2015 Season for Children 2–17 Years by Vaccine Type: US Influenza Vaccine Effectiveness Network Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv131.142 |
0.574 |
|
| 2015 |
Fry AM, Gubareva L, Garten R, Clippard J, Mishin V, Spencer S, Thaker S, Nowalk MP, Jackson ML, Jackson LA, Monto A, Zimmerman RK, Petrie JG, Belongia E, Mclean HQ, et al. Influenza Vaccine Effectiveness Against Drifted Versus Vaccine-Like A/H3N2 Viruses During the 2014-15 Influenza Season—US Flu VE Network Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv131.141 |
0.609 |
|
| 2015 |
Havers F, Hicks L, Clippard J, Gaglani M, Zimmerman RK, Jackson ML, Petrie JG, Mclean HQ, Nowalk MP, Monto A, Belongia E, Eng H, Flannery B, Fry AM. Outpatient Antibiotic Prescribing for Acute Respiratory Illnesses Including Influenza During the 2013–14 Influenza Season Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv131.128 |
0.532 |
|
| 2014 |
de Jong MD, Ison MG, Monto AS, Metev H, Clark C, O'Neil B, Elder J, McCullough A, Collis P, Sheridan WP. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: e172-85. PMID 25115871 DOI: 10.1093/Cid/Ciu632 |
0.429 |
|
| 2014 |
Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, Nowalk MP, Moehling KK, Flannery B, Thompson MG, Fry AM. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 774-82. PMID 25034419 DOI: 10.1093/Cid/Ciu422 |
0.548 |
|
| 2014 |
Monto AS, Malosh RE, Petrie JG, Thompson MG, Ohmit SE. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. The Journal of Infectious Diseases. 210: 1792-9. PMID 24907381 DOI: 10.1093/Infdis/Jiu327 |
0.359 |
|
| 2014 |
Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Berman L, Foust A, Sessions W, et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. Mmwr. Morbidity and Mortality Weekly Report. 63: 137-42. PMID 24553196 |
0.576 |
|
| 2014 |
Malosh R, Ohmit SE, Petrie JG, Thompson MG, Aiello AE, Monto AS. Factors associated with influenza vaccine receipt in community dwelling adults and their children. Vaccine. 32: 1841-7. PMID 24530926 DOI: 10.1016/J.Vaccine.2014.01.075 |
0.524 |
|
| 2014 |
Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, Jackson L, Meece JK, Nowalk MP, Song J, Zervos M, ... ... Monto AS, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 319-27. PMID 24235265 DOI: 10.1093/Cid/Cit736 |
0.616 |
|
| 2014 |
Malosh RE, Ohmit SE, Johnson E, Cross R, Monto A. 1139Risk of influenza after Previous Acute Respiratory Illness in a Cohort of Households with Children Open Forum Infectious Diseases. 1: S338-S338. DOI: 10.1093/Ofid/Ofu052.847 |
0.427 |
|
| 2014 |
Clippard J, Thaker S, Monto A, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson M, Jackson LA, Belongia E, Mclean H, Spencer S, Fry A, Flannery B. 650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network Open Forum Infectious Diseases. 1: S35-S35. DOI: 10.1093/Ofid/Ofu051.95 |
0.534 |
|
| 2014 |
Flannery B, Thaker S, Clippard J, Monto A, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson M, Jackson LA, Belongia E, Mclean H, Berman L, Foust A, Sessions W, et al. 535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network Open Forum Infectious Diseases. 1: S20-S20. DOI: 10.1093/Ofid/Ofu051.54 |
0.599 |
|
| 2014 |
Petrie JG, Ohmit SE, Cross R, Monto A. 533Persistence of Antibody to Influenza Hemagglutinin over Two Influenza Seasons Open Forum Infectious Diseases. 1: S19-S19. DOI: 10.1093/Ofid/Ofu051.52 |
0.538 |
|
| 2013 |
Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 31: 6030-3. PMID 24095882 DOI: 10.1016/J.Vaccine.2013.09.063 |
0.617 |
|
| 2013 |
Petrie JG, Ohmit SE, Cowling BJ, Johnson E, Cross RT, Malosh RE, Thompson MG, Monto AS. Influenza transmission in a cohort of households with children: 2010-2011. Plos One. 8: e75339. PMID 24086511 DOI: 10.1371/Journal.Pone.0075339 |
0.473 |
|
| 2013 |
Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, et al. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza and Other Respiratory Viruses. 7: 52-3. PMID 24034484 DOI: 10.1111/Irv.12081 |
0.613 |
|
| 2013 |
Gessner BD, Brooks WA, Neuzil KM, Vernet G, Bright RA, Tam JS, Bresee J, Monto AS. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine. 31: 3222-8. PMID 23707161 DOI: 10.1016/J.Vaccine.2013.05.017 |
0.599 |
|
| 2013 |
Monto AS, Ohmit SE. Reply to Sullivan and Kelly and Skowronski et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 477-8. PMID 23619810 DOI: 10.1093/Cid/Cit259 |
0.568 |
|
| 2013 |
Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1363-9. PMID 23413420 DOI: 10.1093/Cid/Cit060 |
0.599 |
|
| 2013 |
Jackson L, Jackson ML, Phillips CH, Benoit J, Belongia EA, Cole D, Kopitzke S, Kronenwetter Koepel TA, McLean HQ, Meece JK, Strey SK, Sundaram ME, Vandermause M, Gaglani M, Song J, ... ... Monto AS, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2013 Morbidity and Mortality Weekly Report. 62: 32-35. PMID 23325354 |
0.529 |
|
| 2013 |
Whitley RJ, Boucher CA, Lina B, Nguyen-Van-Tam JS, Osterhaus A, Schutten M, Monto AS. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1197-205. PMID 23307766 DOI: 10.1093/Cid/Cis1220 |
0.482 |
|
| 2012 |
Uzicanin A, Thompson M, Smith P, Chaves SS, Foster L, Dube N, Graitcer S, Jackson R, Ferdinands J, Gargiullo P, Mills D, Monto AS, Shay DK. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine. The Journal of Infectious Diseases. 206: 1059-68. PMID 22850120 DOI: 10.1093/Infdis/Jis441 |
0.587 |
|
| 2012 |
Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 951-9. PMID 22843783 DOI: 10.1093/Cid/Cis574 |
0.601 |
|
| 2012 |
Van Kerkhove MD, Riley S, Lipsitch M, Guan Y, Monto AS, Webster RG, Zambon M, Nicoll A, Peiris JS, Ferguson NM. Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science (New York, N.Y.). 336: 1506; author reply 1. PMID 22723396 DOI: 10.1126/Science.1221434 |
0.443 |
|
| 2012 |
Monto AS, Ohmit SE. Editorial commentary: seasonal influenza vaccines during the 2009 pandemic: help or harm? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 703-5. PMID 22670047 DOI: 10.1093/Cid/Cis526 |
0.623 |
|
| 2012 |
Graitcer SB, Dube NL, Basurto-Davila R, Smith PF, Ferdinands J, Thompson M, Uzicanin A, Gargiullo P, Chaves SS, Robinson S, Sears S, Tipton M, Monto AS, Mills D, Shay DK. Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine. Vaccine. 30: 4835-41. PMID 22609012 DOI: 10.1016/J.Vaccine.2012.05.008 |
0.456 |
|
| 2012 |
Aiello AE, Perez V, Coulborn RM, Davis BM, Uddin M, Monto AS. Facemasks, hand hygiene, and influenza among young adults: a randomized intervention trial. Plos One. 7: e29744. PMID 22295066 DOI: 10.1371/Journal.Pone.0029744 |
0.525 |
|
| 2012 |
Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, ... Monto A, et al. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza and Other Respiratory Viruses. 6: 142-52, e1-5. PMID 21819547 DOI: 10.1111/J.1750-2659.2011.00277.X |
0.618 |
|
| 2012 |
Perez V, Uddin M, Galea S, Monto AS, Aiello AE. Stress, adherence to preventive measures for reducing influenza transmission and influenza-like illness. Journal of Epidemiology and Community Health. 66: 605-10. PMID 21224242 DOI: 10.1136/Jech.2010.117002 |
0.412 |
|
| 2011 |
Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. The Journal of Infectious Diseases. 204: 1879-85. PMID 21998477 DOI: 10.1093/Infdis/Jir661 |
0.586 |
|
| 2011 |
Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. Plos One. 6: e23085. PMID 21857999 DOI: 10.1371/Journal.Pone.0023085 |
0.613 |
|
| 2011 |
Monto AS, Black S, Plotkin SA, Orenstein WA. Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries. Vaccine. 29: 6427-31. PMID 21763381 DOI: 10.1016/J.Vaccine.2011.06.113 |
0.601 |
|
| 2011 |
Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. The Journal of Infectious Diseases. 203: 1309-15. PMID 21378375 DOI: 10.1093/Infdis/Jir015 |
0.568 |
|
| 2011 |
Sutherland TC, Welkers MRA, Osterhaus ADME, Monto A, De Jong MD, Hayden FG. Current research on respiratory viral infections: XIII International Symposium on Respiratory Viral Infections: Part 2 Future Virology. 6: 1283-1288. DOI: 10.2217/Fvl.11.97 |
0.398 |
|
| 2010 |
Monto AS. Seasonal influenza and vaccination coverage. Vaccine. 28: D33-44. PMID 20713259 DOI: 10.1016/J.Vaccine.2010.08.027 |
0.555 |
|
| 2010 |
Monto AS. Seasonal influenza vaccinations: specialized products for different target groups. Vaccine. 28: D14-23. PMID 20713256 DOI: 10.1016/J.Vaccine.2010.08.025 |
0.555 |
|
| 2010 |
Carney PJ, Lipatov AS, Monto AS, Donis RO, Stevens J. Flexible label-free quantitative assay for antibodies to influenza virus hemagglutinins. Clinical and Vaccine Immunology : Cvi. 17: 1407-16. PMID 20660137 DOI: 10.1128/Cvi.00509-09 |
0.482 |
|
| 2010 |
Aiello AE, Coulborn RM, Aragon TJ, Baker MG, Burrus BB, Cowling BJ, Duncan A, Enanoria W, Fabian MP, Ferng YH, Larson EL, Leung GM, Markel H, Milton DK, Monto AS, et al. Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. American Journal of Infection Control. 38: 251-8. PMID 20226569 DOI: 10.1016/J.Ajic.2009.12.007 |
0.537 |
|
| 2010 |
Aiello AE, Murray GF, Perez V, Coulborn RM, Davis BM, Uddin M, Shay DK, Waterman SH, Monto AS. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. The Journal of Infectious Diseases. 201: 491-8. PMID 20088690 DOI: 10.1086/650396 |
0.5 |
|
| 2010 |
Uddin M, Cherkowski GC, Liu G, Zhang J, Monto AS, Aiello AE. Demographic and socioeconomic determinants of influenza vaccination disparities among university students Journal of Epidemiology and Community Health. 64: 808-813. PMID 19828514 DOI: 10.1136/Jech.2009.090852 |
0.554 |
|
| 2010 |
Aiello A, Coulborn R, Perez V, Davis B, Uddin M, Murray G, Shay D, Waterman S, Monto A. A randomized intervention trial of mask use and hand hygiene to reduce seasonal influenza-like illness and influenza infections among young adults in a university setting International Journal of Infectious Diseases. 14: e320. DOI: 10.1016/J.Ijid.2010.02.2201 |
0.484 |
|
| 2010 |
Perez V, Galea S, Kalbfleisch J, Monto A, Aiello A. The effect of influenza-like illness symptoms and laboratory confirmed influenza A on hand hygiene and other health habits among US University students International Journal of Infectious Diseases. 14: e99. DOI: 10.1016/J.Ijid.2010.02.1706 |
0.454 |
|
| 2010 |
Monto A. International response to the H1N1 pandemic International Journal of Infectious Diseases. 14: e22. DOI: 10.1016/j.ijid.2010.02.1534 |
0.317 |
|
| 2010 |
Monto A. Overcoming limitations of seasonal vaccines International Journal of Infectious Diseases. 14: e12-e13. DOI: 10.1016/j.ijid.2010.02.1508 |
0.411 |
|
| 2010 |
Monto AS. The Epidemiology of Viral Infections Topley and Wilson's Microbiology and Microbial Infections. DOI: 10.1002/9780470688618.Taw0224 |
0.37 |
|
| 2009 |
Eisenberg JN, Aiello AE, Spicknall IH, Monto AS, Reingold A. Protecting the herd from H1N1. Science (New York, N.Y.). 326: 934; author reply 93. PMID 19965495 DOI: 10.1126/Science.326.5955.934-A |
0.549 |
|
| 2009 |
Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC. Comparative efficacy of inactivated and live attenuated influenza vaccines. The New England Journal of Medicine. 361: 1260-7. PMID 19776407 DOI: 10.1056/Nejmoa0808652 |
0.758 |
|
| 2009 |
Monto AS. Implications of antiviral resistance of influenza viruses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 397-9. PMID 19586376 DOI: 10.1086/596312 |
0.484 |
|
| 2009 |
Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, Puig-Barberà J, Schmitt J, Stephenson I. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 27: 5043-53. PMID 19559118 DOI: 10.1016/J.Vaccine.2009.06.032 |
0.564 |
|
| 2009 |
Monto AS, Ohmit SE. Seasonal influenza vaccines: evolutions and future trends. Expert Review of Vaccines. 8: 383-9. PMID 19348555 DOI: 10.1586/Erv.09.9 |
0.556 |
|
| 2009 |
Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, Ferng YH, Morse SS, Larson EL, Aiello AE, Davis B, Monto AS. Low sensitivity of rapid diagnostic test for influenza. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: e89-92. PMID 19323628 DOI: 10.1086/597828 |
0.412 |
|
| 2009 |
Layne SP, Monto AS, Taubenberger JK. Pandemic influenza: an inconvenient mutation. Science (New York, N.Y.). 323: 1560-1. PMID 19299601 DOI: 10.1126/Science.323.5921.1560 |
0.554 |
|
| 2009 |
Ohmit SE, Gross J, Victor JC, Monto AS. Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. Vaccine. 27: 1050-4. PMID 19095028 DOI: 10.1016/J.Vaccine.2008.11.100 |
0.705 |
|
| 2009 |
Monto AS. The risk of seasonal and pandemic influenza: prospects for control. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: S20-5. PMID 19067611 DOI: 10.1086/591853 |
0.598 |
|
| 2009 |
Jennings LC, Nicholson KG, Monto AS. Prepandemic influenza vaccines - Authors' reply The Lancet Infectious Diseases. 9: 207-209. DOI: 10.1016/S1473-3099(09)70084-2 |
0.588 |
|
| 2008 |
Monto AS. Epidemiology of influenza. Vaccine. 26: D45-8. PMID 19230159 DOI: 10.1016/J.Vaccine.2008.07.066 |
0.512 |
|
| 2008 |
Jennings LC, Monto AS, Chan PK, Szucs TD, Nicholson KG. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. The Lancet. Infectious Diseases. 8: 650-8. PMID 18922487 DOI: 10.1016/S1473-3099(08)70232-9 |
0.626 |
|
| 2008 |
Monto AS. Antivirals and influenza: frequency of resistance. The Pediatric Infectious Disease Journal. 27: S110-2. PMID 18820569 DOI: 10.1097/Inf.0B013E318168B739 |
0.455 |
|
| 2008 |
Monto AS. Editorial commentary: viral susceptibility and the choice of influenza antivirals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 346-8. PMID 18582205 DOI: 10.1086/589749 |
0.528 |
|
| 2008 |
Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, Newton DW, Campbell SA, Boulton ML, Monto AS. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. The Journal of Infectious Diseases. 198: 312-7. PMID 18522501 DOI: 10.1086/589885 |
0.754 |
|
| 2008 |
Monto AS, Whitley RJ. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1024-31. PMID 18444819 DOI: 10.1086/528720 |
0.592 |
|
| 2008 |
Perez V, Aiello A, Murray G, Coulborn R, Monto A. Fear, Stress, and Reported Pandemic Influenza Response among University Students in the US International Journal of Infectious Diseases. 12: e444. DOI: 10.1016/J.Ijid.2008.05.1292 |
0.367 |
|
| 2007 |
Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. The New England Journal of Medicine. 357: 1685-94. PMID 17947390 DOI: 10.1056/Nejmoa070546 |
0.683 |
|
| 2007 |
Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American Journal of Epidemiology. 165: 212-21. PMID 17088311 DOI: 10.1093/Aje/Kwj362 |
0.42 |
|
| 2006 |
Markel H, Stern AM, Navarro JA, Michalsen JR, Monto AS, DiGiovanni C. Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic. Emerging Infectious Diseases. 12: 1961-4. PMID 17326953 DOI: 10.3201/Eid1212.060506 |
0.472 |
|
| 2006 |
Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. The New England Journal of Medicine. 355: 2513-22. PMID 17167134 DOI: 10.1056/Nejmoa061850 |
0.763 |
|
| 2006 |
Monto AS, Comanor L, Shay DK, Thompson WW. Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. The Journal of Infectious Diseases. 194: S92-7. PMID 17163395 DOI: 10.1086/507559 |
0.476 |
|
| 2006 |
Whitley RJ, Monto AS. Seasonal and pandemic influenza preparedness: a global threat. The Journal of Infectious Diseases. 194: S65-9. PMID 17163390 DOI: 10.1086/507562 |
0.535 |
|
| 2006 |
Whitley RJ, Bartlett J, Hayden FG, Pavia AT, Tapper M, Monto AS. Seasonal and pandemic influenza: recommendations for preparedness in the United States. The Journal of Infectious Diseases. 194: S155-61. PMID 17163389 DOI: 10.1086/507557 |
0.492 |
|
| 2006 |
Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. The Journal of Infectious Diseases. 194: S133-8. PMID 17163386 DOI: 10.1086/507548 |
0.429 |
|
| 2006 |
Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics. 118: e579-85. PMID 16950949 DOI: 10.1542/Peds.2006-0201 |
0.582 |
|
| 2006 |
Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Pediatrics. 118: e570-8. PMID 16950948 DOI: 10.1542/Peds.2006-0198 |
0.581 |
|
| 2006 |
Yen HL, Hoffmann E, Taylor G, Scholtissek C, Monto AS, Webster RG, Govorkova EA. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses. Journal of Virology. 80: 8787-95. PMID 16912325 DOI: 10.1128/Jvi.00477-06 |
0.573 |
|
| 2006 |
Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 564-8. PMID 16886147 DOI: 10.1086/506352 |
0.549 |
|
| 2006 |
Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrobial Agents and Chemotherapy. 50: 2395-402. PMID 16801417 DOI: 10.1128/Aac.01339-05 |
0.442 |
|
| 2006 |
Monto AS. Antivirals for influenza in healthy adults. Lancet (London, England). 367: 1571-2; author reply. PMID 16698401 DOI: 10.1016/S0140-6736(06)68684-4 |
0.465 |
|
| 2006 |
Bell D, Nicoll A, Fukuda K, Horby P, Monto A, Hayden F, Wylks C, Sanders L, van Tam J. Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerging Infectious Diseases. 12: 88-94. PMID 16494723 DOI: 10.3201/eid1201.051371 |
0.319 |
|
| 2006 |
Bell D, Nicoll A, Fukuda K, Horby P, Monto A, Hayden F, Wylks C, Sanders L, Van Tam J. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerging Infectious Diseases. 12: 81-7. PMID 16494722 DOI: 10.3201/eid1201.051370 |
0.44 |
|
| 2006 |
Monto AS. Vaccines and antiviral drugs in pandemic preparedness. Emerging Infectious Diseases. 12: 55-60. PMID 16494718 DOI: 10.3201/Eid1201.051068 |
0.583 |
|
| 2006 |
Victor JC, Surdina TY, Suleimenova SZ, Favorov MO, Bell BP, Monto AS. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. American Journal of Epidemiology. 163: 204-10. PMID 16339053 DOI: 10.1093/Aje/Kwj029 |
0.691 |
|
| 2006 |
Victor JC, Surdina TY, Suleimeova SZ, Favorov MO, Bell BP, Monto AS. The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity. Epidemiology and Infection. 134: 492-7. PMID 16194291 DOI: 10.1017/S0950268805005194 |
0.583 |
|
| 2006 |
Victor J, Monto A, Surdina T, Suleimenova S, Favorov M, Bell B. P.343 The relative efficacy of hepatitis A vaccine versus immune globulin for postexposure prophylaxis Journal of Clinical Virology. 36: S166-S167. DOI: 10.1016/S1386-6532(06)80517-2 |
0.658 |
|
| 2005 |
Cinti S, Chenoweth C, Monto AS. Preparing for pandemic influenza: should hospitals stockpile oseltamivir? Infection Control and Hospital Epidemiology. 26: 852-4. PMID 16320980 DOI: 10.1086/502507 |
0.592 |
|
| 2005 |
Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, Govorkova EA. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrobial Agents and Chemotherapy. 49: 4075-84. PMID 16189083 DOI: 10.1128/Aac.49.10.4075-4084.2005 |
0.622 |
|
| 2005 |
Yen HL, Monto AS, Webster RG, Govorkova EA. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. The Journal of Infectious Diseases. 192: 665-72. PMID 16028136 DOI: 10.1086/432008 |
0.631 |
|
| 2005 |
Fleming DM, Monto AS, Bueving HJ, Thomas S, Van Der Wouden JC. Influenza vaccination in children with asthma: No reason to change current recommendations (multiple letters) American Journal of Respiratory and Critical Care Medicine. 171: 931-932. PMID 15817807 DOI: 10.1164/Ajrccm.171.8.951 |
0.503 |
|
| 2005 |
Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 115: 1039-47. PMID 15805382 DOI: 10.1542/Peds.2004-2373 |
0.529 |
|
| 2005 |
Monto AS. The threat of an avian influenza pandemic. The New England Journal of Medicine. 352: 323-5. PMID 15668220 DOI: 10.1056/Nejmp048343 |
0.369 |
|
| 2005 |
Fleming DM, Monto AS. Influenza Vaccination in Children with Asthma American Journal of Respiratory and Critical Care Medicine. 171: 931-931. DOI: 10.1164/Ajrccm.171.8.950 |
0.515 |
|
| 2004 |
Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. The Journal of Infectious Diseases. 190: 1627-30. PMID 15478068 DOI: 10.1086/424572 |
0.639 |
|
| 2004 |
Monto AS, Rotthoff J, Teich E, Herlocher ML, Truscon R, Yen HL, Elias S, Ohmit SE. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 459-64. PMID 15356805 DOI: 10.1086/422646 |
0.696 |
|
| 2004 |
Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Echinacea purpurea for prevention of experimental rhinovirus colds. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 1367-71. PMID 15156472 DOI: 10.1086/386324 |
0.313 |
|
| 2004 |
Fedson DS, Monto AS. Vaccination for pandemic influenza: A six point agenda for interpandemic years Pediatric Infectious Disease Journal. 23. PMID 14730273 |
0.482 |
|
| 2004 |
Monto AS. Occurrence of respiratory virus: time, place and person. The Pediatric Infectious Disease Journal. 23: S58-64. PMID 14730271 DOI: 10.1097/01.Inf.0000108193.91607.34 |
0.416 |
|
| 2004 |
Monto AS. Global burden of influenza: what we know and what we need to know International Congress Series. 1263: 3-11. DOI: 10.1016/j.ics.2004.02.049 |
0.431 |
|
| 2003 |
Herlocher ML, Truscon R, Fenton R, Klimov A, Elias S, Ohmit SE, Monto AS. Assessment of development of resistance to antivirals in the ferret model of influenza virus infection. The Journal of Infectious Diseases. 188: 1355-61. PMID 14593594 DOI: 10.1086/379049 |
0.482 |
|
| 2003 |
Monto AS. Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. American Journal of Epidemiology. 158: 312-5. PMID 12915496 DOI: 10.1093/Aje/Kwg164 |
0.563 |
|
| 2003 |
Monto AS. The role of antivirals in the control of influenza. Vaccine. 21: 1796-800. PMID 12686097 DOI: 10.1016/S0264-410X(03)00075-6 |
0.466 |
|
| 2003 |
Loughlin J, Poulios N, Napalkov P, Wegmüller Y, Monto AS. A study of influenza and influenza-related complications among children in a large US health insurance plan database. Pharmacoeconomics. 21: 273-83. PMID 12600222 DOI: 10.2165/00019053-200321040-00005 |
0.509 |
|
| 2003 |
Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives of Internal Medicine. 163: 487-94. PMID 12588210 DOI: 10.1001/Archinte.163.4.487 |
0.438 |
|
| 2003 |
Cooper NJ, Sutton AJ, Abrams KR, Scuffham PA, Monto AS. Oseltamivir and zanamivir are effective for treating influenza, but preventive effects are unclear Evidence-Based Healthcare. 7: 205-207. DOI: 10.1016/j.ehbc.2003.09.001 |
0.407 |
|
| 2002 |
Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clinical Therapeutics. 24: 1987-97. PMID 12581541 DOI: 10.1016/S0149-2918(02)80093-5 |
0.335 |
|
| 2002 |
Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. The Journal of Infectious Diseases. 186: 1582-8. PMID 12447733 DOI: 10.1086/345722 |
0.503 |
|
| 2002 |
Herlocher ML, Carr J, Ives J, Elias S, Truscon R, Roberts N, Monto AS. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets Antiviral Research. 54: 99-111. PMID 12062395 DOI: 10.1016/S0166-3542(01)00214-5 |
0.48 |
|
| 2002 |
Monto AS. Epidemiology of viral respiratory infections. The American Journal of Medicine. 112: 4S-12S. PMID 11955454 DOI: 10.1067/Mda.2003.17 |
0.363 |
|
| 2002 |
Blitz SG, Cram P, Chernew ME, Monto AS, Fendrick AM. Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. The American Journal of Managed Care. 8: 221-7. PMID 11915972 |
0.328 |
|
| 2001 |
Monto AS, Fendrick AM, Sarnes MW. Respiratory illness caused by picornavirus infection: A review of clinical outcomes Clinical Therapeutics. 23: 1615-1627. PMID 11726001 DOI: 10.1016/S0149-2918(01)80133-8 |
0.338 |
|
| 2001 |
Herlocher ML, Elias S, Truscon R, Harrison S, Mindell D, Simon C, Monto AS. Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. The Journal of Infectious Diseases. 184: 542-6. PMID 11494159 DOI: 10.1086/322801 |
0.495 |
|
| 2001 |
Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: A cohort study American Journal of Epidemiology. 154: 155-160. PMID 11447049 DOI: 10.1093/Aje/154.2.155 |
0.561 |
|
| 2001 |
Cram P, Blitz S, Monto A, Fendrick A. Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies Pharmacoeconomics. 19: 223-230. PMID 11303411 DOI: 10.2165/00019053-200119030-00001 |
0.604 |
|
| 2001 |
Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. Jama. 285: 748-54. PMID 11176912 DOI: 10.1001/Jama.285.6.748 |
0.542 |
|
| 2001 |
Herlocher M, Fenton R, Merry A, Elias S, Monto AS. Influenza resistance to zanamivir generated in ferrets International Congress Series. 1219: 863-877. DOI: 10.1016/S0531-5131(01)00365-X |
0.345 |
|
| 2001 |
Monto AS. Influenza future: the impact of new vaccines and antivirals International Congress Series. 1219: 53-59. DOI: 10.1016/S0531-5131(01)00325-9 |
0.506 |
|
| 2000 |
Monto AS, Moult AB, Sharp SJ. Effect of zanamivir on duration and resolution of influenza symptoms Clinical Therapeutics. 22: 1294-1305. PMID 11117654 DOI: 10.1016/S0149-2918(00)83026-X |
0.358 |
|
| 2000 |
Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection Archives of Internal Medicine. 160: 3243-3247. PMID 11088084 DOI: 10.1001/Archinte.160.21.3243 |
0.51 |
|
| 2000 |
Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliott MJ, Hammond JM, Sharp SJ, Ossi MJ. Inhaled zanamivir for the prevention of influenza in families New England Journal of Medicine. 343: 1282-1289. PMID 11058672 DOI: 10.1056/Nejm200011023431801 |
0.452 |
|
| 2000 |
Monto AS. Preventing influenza in healthy adults: The evolving story Journal of the American Medical Association. 284: 1699-1701. PMID 11015802 DOI: 10.1001/Jama.284.13.1699 |
0.602 |
|
| 2000 |
Monto AS. Epidemiology and virology of influenza illness American Journal of Managed Care. 6. PMID 10977472 |
0.501 |
|
| 2000 |
Monto AS. Updating the approach to influenza Hospital Practice. 35: 37-38+43. DOI: 10.3810/Hp.2000.12.222 |
0.548 |
|
| 2000 |
Monto AS, Fendrick AM. Developments in influenza prevention and treatment: A managed care perspective Disease Management and Health Outcomes. 7: 235-243. DOI: 10.2165/00115677-200007050-00001 |
0.503 |
|
| 2000 |
Monto AS, Fendrick AM. Developments in Influenza Prevention and Treatment Disease Management and Health Outcomes. 7: 235-243. DOI: 10.2165/00115677-200007050-00001 |
0.373 |
|
| 2000 |
Monto AS, Fleming DM, Henry D. Zanamivir speeds symptom relief in influenza: Commentary Evidence-Based Medicine. 5: 80-81. DOI: 10.1136/ebm.5.3.80 |
0.308 |
|
| 2000 |
Monto AS. Acute respiratory infections in childhood prospects for vaccine prevention Annales Nestle. 58: 66-73. |
0.393 |
|
| 1999 |
Monto AS. Individual and community impact of influenza Pharmacoeconomics. 16: 1-6. PMID 10623371 DOI: 10.2165/00019053-199916001-00001 |
0.491 |
|
| 1999 |
Monto AS. Francis field trial of inactivated poliomyelitis vaccine: Background and lessons for today Epidemiologic Reviews. 21: 7-23. PMID 10520470 DOI: 10.1093/Oxfordjournals.Epirev.A017989 |
0.408 |
|
| 1999 |
Monto AS, Victor JC. Hepatitis A vaccine for secondary hepatitis A infection. Lancet (London, England). 354: 341-2; author reply . PMID 10440344 DOI: 10.1016/S0140-6736(05)75252-1 |
0.625 |
|
| 1999 |
Monto AS, Robinson DP, Herlocher ML, Hinson JM, Elliott MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. Jama. 282: 31-5. PMID 10404908 DOI: 10.1001/Jama.282.1.31 |
0.505 |
|
| 1999 |
Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T, Elliott M, Keene ON, Man CY. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. The Journal of Infectious Diseases. 180: 254-61. PMID 10395837 DOI: 10.1086/314904 |
0.345 |
|
| 1999 |
Monto AS. The disappearance of Reye's syndrome - A public health triumph New England Journal of Medicine. 340: 1423-1424. PMID 10228195 DOI: 10.1056/Nejm199905063401809 |
0.346 |
|
| 1999 |
Monto AS. Interrupting the transmission of respiratory tract infections: Theory and practice Clinical Infectious Diseases. 28: 200-204. PMID 10064226 DOI: 10.1086/515113 |
0.536 |
|
| 1999 |
Ohmit SE, Arden NH, Monto AS. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic Journal of the American Geriatrics Society. 47: 165-171. PMID 9988287 DOI: 10.1111/J.1532-5415.1999.Tb04574.X |
0.559 |
|
| 1999 |
Monto AS, Keene ON, Webster A, McCarthy TP. Zanamivir studies in the treatment of influenza: An analysis of pooled efficacy data Thorax. 54: A23. |
0.335 |
|
| 1998 |
Monto AS, Lehmann D. Acute respiratory infections (ARI) in children: prospects for prevention. Vaccine. 16: 1582-8. PMID 9711807 DOI: 10.1016/S0264-410X(98)00049-8 |
0.53 |
|
| 1997 |
Monto AS, Iacuzio DA, La Montagne JR. Pandemic influenza - Confronting a reemergent threat Journal of Infectious Diseases. 176. PMID 9254298 |
0.461 |
|
| 1997 |
Monto AS. Prospects for pandemic influenza control with currently available vaccines and antivirals Journal of Infectious Diseases. 176. PMID 9240692 DOI: 10.1086/514172 |
0.586 |
|
| 1997 |
Monto AS, Iacuzio DA, Montagne JRL. Pandemic Influenza—Confronting a Reemergent Threat The Journal of Infectious Diseases. 176. DOI: 10.1086/514167 |
0.495 |
|
| 1996 |
Monto AS. The clinical efficacy of influenza vaccination Pharmacoeconomics. 9: 16-22. PMID 10160482 DOI: 10.2165/00019053-199600093-00006 |
0.616 |
|
| 1996 |
Ohmit SE, Moler FW, Monto AS, Khan AS. Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection Journal of Clinical Epidemiology. 49: 963-967. PMID 8780603 DOI: 10.1016/0895-4356(96)00137-0 |
0.33 |
|
| 1996 |
Monto AS, Terpenning MS. The value of influenza and pneumococcal vaccines in the elderly Drugs and Aging. 8: 445-451. PMID 8736628 DOI: 10.2165/00002512-199608060-00006 |
0.527 |
|
| 1996 |
Monto AS. Viral respiratory tract infections in the immunocompetent Current Opinion in Infectious Diseases. 9: 85-88. DOI: 10.1097/00001432-199604000-00008 |
0.536 |
|
| 1995 |
Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons International Journal of Epidemiology. 24: 1240-1248. PMID 8824869 DOI: 10.1093/Ije/24.6.1240 |
0.612 |
|
| 1995 |
Monto AS, Ohmit SE, Hornbuckle K, Pearce CL. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes Antimicrobial Agents and Chemotherapy. 39: 2224-2228. PMID 8619572 DOI: 10.1128/Aac.39.10.2224 |
0.497 |
|
| 1995 |
Monto AS. Viral respiratory infections in the community: Epidemiology, agents, and interventions The American Journal of Medicine. 99. PMID 8585553 DOI: 10.1016/S0002-9343(99)80307-6 |
0.609 |
|
| 1995 |
Monto AS, Ohmit SE, Margulies JR, Talsma A. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. American Journal of Epidemiology. 141: 502-6. PMID 7900716 DOI: 10.1093/Oxfordjournals.Aje.A117464 |
0.549 |
|
| 1995 |
Arden N, Monto AS, Ohmit SE. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic American Journal of Public Health. 85: 399-401. PMID 7892927 DOI: 10.2105/Ajph.85.3.399 |
0.484 |
|
| 1995 |
Monto AS, Davies, Busse, Orie, Sprenger, Rothbarth, Quanjer. Epidemiology of respiratory viruses in persons with and without asthma and COPD American Journal of Respiratory and Critical Care Medicine. 151: 1653-1658. PMID 7735629 DOI: 10.1164/Ajrccm/151.5_Pt_1.1653 |
0.403 |
|
| 1995 |
Ohmit SE, Furumoto-Dawson A, Monto AS, Fasano N. Influenza vaccine use among an elderly population in a community intervention American Journal of Preventive Medicine. 11: 271-276. PMID 7495605 DOI: 10.1016/S0749-3797(18)30457-4 |
0.483 |
|
| 1994 |
Monto AS. Influenza vaccines for the elderly New England Journal of Medicine. 331: 807-808. PMID 8065412 DOI: 10.1056/Nejm199409223311212 |
0.614 |
|
| 1994 |
Monto AS. Using antiviral agents to control outbreaks of influenza A infection Geriatrics. 49: 30-34. PMID 7982583 |
0.49 |
|
| 1994 |
Monto AS. Studies of the community and family: Acute respiratory illness and infection Epidemiologic Reviews. 16: 351-373. PMID 7713184 DOI: 10.1093/Oxfordjournals.Epirev.A036158 |
0.343 |
|
| 1993 |
Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, Rekstin AR, Beljaev AL, Bragina VE, Cox N, Ghendon YZ, Alexandrova GIA. Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Schoolchildren and Their Unvaccinated Contacts in Novgorod, Russia Journal of Infectious Diseases. 168: 881-887. PMID 8376833 DOI: 10.1093/Infdis/168.4.881 |
0.575 |
|
| 1993 |
Sullivan KM, Monto AS, Longini IM. Estimates of the US health impact of influenza American Journal of Public Health. 83: 1712-1716. PMID 8259800 DOI: 10.2105/Ajph.83.12.1712 |
0.468 |
|
| 1992 |
Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza a Clinical Infectious Diseases. 15: 362-367. PMID 1520770 DOI: 10.1093/Clinids/15.2.362 |
0.495 |
|
| 1992 |
Foster DA, Talsma A, Furumoto-Dawson A, Ohmit SE, Margulies JR, Arden NH, Monto AS. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology. 136: 296-307. PMID 1415151 DOI: 10.1093/Oxfordjournals.Aje.A116495 |
0.611 |
|
| 1992 |
Rampey AH, Longini IM, Haber M, Monto AS. A discrete-time model for the statistical analysis of infectious disease incidence data. Biometrics. 48: 117-128. DOI: 10.2307/2532743 |
0.308 |
|
| 1990 |
Monto AS, Obmit S. Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965 Journal of Infectious Diseases. 161: 781-783. PMID 2319169 DOI: 10.1093/Infdis/161.4.781 |
0.362 |
|
| 1990 |
Sullivan KM, Monto AS, Foster DA. Antibody response to inactivated influenza vaccines of various antigenic concentrations. The Journal of Infectious Diseases. 161: 333-5. PMID 2299213 DOI: 10.1093/Infdis/161.2.333 |
0.533 |
|
| 1989 |
Koopman JS, Monto AS, Ira M L. The tecumseh study XVI: Family and community sources of rotavirus infection American Journal of Epidemiology. 130: 760-768. PMID 2773919 DOI: 10.1093/Oxfordjournals.Aje.A115397 |
0.32 |
|
| 1989 |
Koopman JS, Monto AS. The tecumseh study XV: Rota virus infection and pathogenicity American Journal of Epidemiology. 130: 750-759. PMID 2549788 DOI: 10.1093/Oxfordjournals.Aje.A115396 |
0.346 |
|
| 1989 |
Monto AS. New vaccines: Introduction, part 2 Clinical Infectious Diseases. 11: S586-S587. DOI: 10.1093/Clinids/11.Supplement_3.S586 |
0.476 |
|
| 1988 |
Longini IM, Monto AS. Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents: A field trial in tecumseh, Michigan American Journal of Epidemiology. 128: 639-644. PMID 2843040 DOI: 10.1093/Oxfordjournals.Aje.A115011 |
0.385 |
|
| 1988 |
Monto AS, Albrecht JK, Schwartz SA. Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon Antimicrobial Agents and Chemotherapy. 32: 47-50. PMID 2831814 DOI: 10.1128/Aac.32.1.47 |
0.371 |
|
| 1987 |
Monto AS. Influenza: Quantifying morbidity and mortality The American Journal of Medicine. 82: 20-25. PMID 3591814 DOI: 10.1016/0002-9343(87)90556-0 |
0.464 |
|
| 1987 |
Monto AS, Bryan ER, Ohmit S. Rhinovirus Infections in Tecumseh, Michigan: Frequency of Illness and Number of Serotypes Journal of Infectious Diseases. 156: 43-49. PMID 3036962 DOI: 10.1093/Infdis/156.1.43 |
0.323 |
|
| 1986 |
Hayden FG, Monto AS. Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults Antimicrobial Agents and Chemotherapy. 29: 339-341. PMID 3521480 |
0.354 |
|
| 1986 |
Monto AS, Koopman JS, Bryan ER. The tecumseh study of illness. XIV: Occurrence OF respiratory viruses, 1970-1981 American Journal of Epidemiology. 124: 359-367. PMID 3017099 DOI: 10.1093/Oxfordjournals.Aje.A114406 |
0.45 |
|
| 1986 |
Monto AS, Shope TC, Schwartz SA, Albrecht JK. Intranasal interferon-α2b for seasonal prophylaxis of respiratory infection Journal of Infectious Diseases. 154: 128-133. PMID 3011917 DOI: 10.1093/Infdis/154.1.128 |
0.311 |
|
| 1985 |
Monto AS, Koopman JS, Longini IM. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981 American Journal of Epidemiology. 121: 811-822. PMID 4014174 DOI: 10.1093/Oxfordjournals.Aje.A114052 |
0.479 |
|
| 1985 |
Miller FD, Monto AS, DeLong DC, Exelby A, Bryan ER, Srivastava S. Controlled trial of enviroxime against natural rhinovirus infections in a community Antimicrobial Agents and Chemotherapy. 27: 102-106. PMID 2984980 DOI: 10.1128/Aac.27.1.102 |
0.315 |
|
| 1984 |
Longini IM, Seaholm SK, Ackerman E, Koopman JS, Monto AS. Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. International Journal of Epidemiology. 13: 496-501. PMID 6519891 DOI: 10.1093/Ije/13.4.496 |
0.383 |
|
| 1984 |
Longini IM, Monto AS, Koopman JS. Statistical procedures for estimating the community probability of illness in family studies: Rhinovirus and influenza International Journal of Epidemiology. 13: 99-106. PMID 6321368 DOI: 10.1093/Ije/13.1.99 |
0.439 |
|
| 1983 |
Monto AS. Prevention and drug treatment of influenza American Family Physician. 28: 165-169. PMID 6650333 |
0.403 |
|
| 1983 |
Wright PF, Cherry JD, Foy HM, Glezen WP, Hall CB, McIntosh K, Monto AS, Parrott RH, Portnoy B, Taber LH. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety Reviews of Infectious Diseases. 5: 758-764. PMID 6353530 DOI: 10.1093/clinids/5.4.758 |
0.515 |
|
| 1982 |
Maassab HF, Kendal AP, Abrams GD, Monto AS. Evaluation of a cold-recombinant influenza virus vaccine in ferrets Journal of Infectious Diseases. 146: 780-790. PMID 7142749 DOI: 10.1093/Infdis/146.6.780 |
0.375 |
|
| 1982 |
Longini IM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza American Journal of Epidemiology. 115: 736-751. PMID 7081204 DOI: 10.1093/Oxfordjournals.Aje.A113356 |
0.508 |
|
| 1982 |
Monto AS, Miller FD, Maassab HF. Evaluation of an attenuated, cold-recombinant influenza b virus vaccine Journal of Infectious Diseases. 145: 57-64. PMID 7054318 DOI: 10.1093/Infdis/145.1.57 |
0.567 |
|
| 1982 |
Koopman JS, Eckert EA, Greenberg HB, Strohm BC, Isaacson RE, Monto AS. Norwalk virus enteric illness acquired by swimming exposure American Journal of Epidemiology. 115: 173-177. PMID 6277185 DOI: 10.1093/Oxfordjournals.Aje.A113288 |
0.412 |
|
| 1982 |
Monto AS. Pure Politics and Impure Science: The Swine Flu Affair Jama: the Journal of the American Medical Association. 247: 3268. DOI: 10.1001/Jama.1982.03320480074038 |
0.383 |
|
| 1981 |
Troisi CL, Monto AS. Comparison of enzyme-linked immunosorbent assay and hemagglutination inhibition in a seroepidemiological study of influenza type C infection Journal of Clinical Microbiology. 14: 516-521. PMID 7309849 |
0.35 |
|
| 1981 |
Monto AS, Ceglarek JP, Hayner NS. Liver function abnormalities in the course of a type a (H1N1) influenza outbreak: Relation to reye's syndrome American Journal of Epidemiology. 114: 750-759. PMID 7304602 DOI: 10.1093/Oxfordjournals.Aje.A113246 |
0.449 |
|
| 1981 |
Monto AS, Maassab HF. Serologic responses to nonprevalent influenza a viruses during intercyclic periods American Journal of Epidemiology. 113: 236-244. PMID 7193408 DOI: 10.1093/Oxfordjournals.Aje.A113092 |
0.497 |
|
| 1980 |
Monto AS, Koopman JS. The tecumseh study: XI. Occurrence of acute enteric illness in the community American Journal of Epidemiology. 112: 323-333. PMID 7424881 DOI: 10.1093/Oxfordjournals.Aje.A112998 |
0.33 |
|
| 1979 |
Monto AS, Gunn RA, Bandyk MG, King CL. Prevention of Russian Influenza by Amantadine Jama: the Journal of the American Medical Association. 241: 1003-1007. PMID 368354 DOI: 10.1001/Jama.1979.03290360019018 |
0.501 |
|
| 1979 |
Monto AS, Ross HW. Swine influenza vaccine program in the community: Acceptability, reactions and responses American Journal of Public Health. 69: 233-237. PMID 217281 |
0.488 |
|
| 1978 |
Austin MAD, Monto AS, Maassab HF. Growth characteristics of influenza virus type C in avian hosts Archives of Virology. 58: 349-353. PMID 736797 DOI: 10.1007/Bf01317827 |
0.456 |
|
| 1978 |
Monto AS, Ross HW. The tecumseh study of respiratory illness: X. Relation of acute infections to smoking, lung function and chronic symptoms American Journal of Epidemiology. 107: 57-64. PMID 623090 DOI: 10.1093/Oxfordjournals.Aje.A112508 |
0.346 |
|
| 1977 |
Monto AS, Ross H. Acute respiratory illness in the community: effect of family composition, smoking, and chronic symptoms British Journal of Preventive and Social Medicine. 31: 101-108. PMID 884394 DOI: 10.1136/Jech.31.2.101 |
0.308 |
|
| 1977 |
Monto AS, Dickson CB. Utilization and acceptability of influenza a/new jersey/76 virus vaccine in oakland county, michigan Journal of Infectious Diseases. 136: S693-S698. PMID 606793 DOI: 10.1093/Infdis/136.Supplement_3.S693 |
0.555 |
|
| 1977 |
Monto AS, Maassab HF. Use of influenza vaccine in non-high risk populations Developments in Biological Standardization. 329-335. PMID 604116 |
0.439 |
|
| 1977 |
Monto AS, Rhodes LM. Detection of coronavirus infection of man by immunofluorescence. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 155: 143-8. PMID 194251 DOI: 10.3181/00379727-155-39761 |
0.304 |
|
| 1975 |
Monto AS, Kioumehr F. The tecumseh study of respiratory illness: Ix. OCCURRENCE of INFLUENZA in THE community, 1966-1971 American Journal of Epidemiology. 102: 553-563. PMID 1202957 DOI: 10.1093/Oxfordjournals.Aje.A112193 |
0.447 |
|
| 1975 |
Oberhofer TR, Brown GC, Monto AS. Seroimmunity to poliomyelitis in an American community American Journal of Epidemiology. 101: 333-339. PMID 164770 DOI: 10.1093/Oxfordjournals.Aje.A112101 |
0.373 |
|
| 1974 |
Monto AS, Lim SK. The Tecumseh study of respiratory illness. VI. Frequency of and relationship between outbreaks of coronavirus infection Journal of Infectious Diseases. 129: 271-276. PMID 4816305 DOI: 10.1093/Infdis/129.3.271 |
0.351 |
|
| 1974 |
Monto AS, Bryan ER, Rhodes LM. The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. American Journal of Epidemiology. 100: 458-68. PMID 4374887 DOI: 10.1093/Oxfordjournals.Aje.A112058 |
0.406 |
|
| 1974 |
Monto AS, Bryan ER. Microneutralization Test for Detection of Rhinovirus Antibodies Proceedings of the Society For Experimental Biology and Medicine. 145: 690-694. PMID 4360649 DOI: 10.3181/00379727-145-37876 |
0.302 |
|
| 1974 |
Monto AS, Ullman BM. Acute Respiratory Illness in an American Community: The Tecumseh Study Jama: the Journal of the American Medical Association. 227: 164-169. PMID 4357298 DOI: 10.1001/Jama.1974.03230150016004 |
0.306 |
|
| 1973 |
Monto AS, Brandt BL, Artenstein MS. Response of children to neisseria meningitidis polysaccharide vaccines Journal of Infectious Diseases. 127: 394-400. PMID 4632878 DOI: 10.1093/Infdis/127.4.394 |
0.446 |
|
| 1973 |
Monto AS. The tecumseh study of respiratory illness: V. Patterns of infection with the parainfluenzaviruses American Journal of Epidemiology. 97: 338-348. PMID 4349692 DOI: 10.1093/Oxfordjournals.Aje.A121514 |
0.328 |
|
| 1973 |
Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet (London, England). 1: 623-5. PMID 4121842 DOI: 10.1016/S0140-6736(73)92196-X |
0.456 |
|
| 1972 |
Monto AS, Cavallaro JJ. The tecumseh study of respiratory illnessiv. Prevalence of rhinovirus serotypes, 1966-19692 American Journal of Epidemiology. 96: 352-360. PMID 4344343 DOI: 10.1093/Oxfordjournals.Aje.A121466 |
0.342 |
|
| 1972 |
Cavallaro JJ, Monto AS. HL Cells, a Sensitive Line for the Isolation and Propagation of Respiratory Syncytial Virus Proceedings of the Society For Experimental Biology and Medicine. 140: 507-510. PMID 4338798 DOI: 10.3181/00379727-140-36491 |
0.36 |
|
| 1971 |
Monto AS, Napier JA, Metzner HL. The tecumseh study of respiratory illness: I. plan of study and observations on syndromes of acute respiratory disease American Journal of Epidemiology. 94: 269-279. PMID 5093655 DOI: 10.1093/Oxfordjournals.Aje.A121320 |
0.321 |
|
| 1971 |
Monto AS, Lim SK. The tecumseh study of respiratory illness: III. Incidence and periodicity of respiratory syncytial virus and mycoplasma pneumoniae infections American Journal of Epidemiology. 94: 290-301. PMID 4328570 DOI: 10.1093/Oxfordjournals.Aje.A121322 |
0.453 |
|
| 1971 |
Monto AS, Cavallaro JJ. The tecumseh study of respiratory illness: II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969 American Journal of Epidemiology. 94: 280-289. PMID 4328569 DOI: 10.1093/Oxfordjournals.Aje.A121321 |
0.4 |
|
| 1970 |
Cavallaro JJ, Monto AS. Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh, Michigan Journal of Infectious Diseases. 122: 272-279. PMID 5504709 DOI: 10.1093/Infdis/122.4.272 |
0.371 |
|
| 1970 |
Monto AS, Davenport FM, Napier JA, Francis T. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. The Journal of Infectious Diseases. 122: 16-25. PMID 5433709 DOI: 10.1093/Infdis/122.1-2.16 |
0.592 |
|
| 1970 |
Monto AS, Cavallaro JJ, Whale EH. Frequency of Arthralgia in Women Receiving One of Three Rubella Vaccines Archives of Internal Medicine. 126: 635-639. PMID 4918712 DOI: 10.1001/Archinte.1970.00310100081009 |
0.442 |
|
| 1970 |
Monto AS, Cavallaro JJ, Keller JB. Seasonal patterns of acute infection in Tecumseh, Mich. Archives of Environmental Health. 21: 408-17. PMID 4323374 DOI: 10.1080/00039896.1970.10667259 |
0.386 |
|
| 1969 |
Monto AS, Davenport FM, Napier JA, Francis T. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bulletin of the World Health Organization. 41: 537-42. PMID 5309469 |
0.525 |
|
| 1969 |
Monto AS. Prevalence of antistreptolysin O in young Panamanians Public Health Reports. 84: 77-79. PMID 4975340 DOI: 10.2307/4593504 |
0.325 |
|
| 1968 |
Monto AS, Johnson KM. Respiratory infections in the American tropics American Journal of Tropical Medicine and Hygiene. 17: 867-874. PMID 4302276 DOI: 10.4269/Ajtmh.1968.17.867 |
0.342 |
|
| 1968 |
Monto AS, Johnson KM. A community study of respiratory infections in the tropics II. The spread of six rhinovirus isolates within the community American Journal of Epidemiology. 88: 55-68. PMID 4298480 DOI: 10.1093/Oxfordjournals.Aje.A120867 |
0.342 |
|
| 1966 |
Monto AS, Olazabal F. Asian influenza in the Panama canal zone: Isolation of a virus variant and protective effect of a vaccine containing a2/Japan/305/57 American Journal of Epidemiology. 83: 101-112. PMID 5910213 DOI: 10.1093/Oxfordjournals.Aje.A120558 |
0.556 |
|
| 1966 |
Monto AS, Johnson KM. Serologic Relationships of the B632 and ECHO-28 Rhinovirus Strains Proceedings of the Society For Experimental Biology and Medicine. 121: 615-619. PMID 4286797 DOI: 10.3181/00379727-121-30844 |
0.309 |
|
| Show low-probability matches. |